Subsequent research in 2015 by Justin M. Oldham et al. revealed a significant interaction between TOLLIP SNPs and N-acetylcysteine (NAC) treatment, suggesting that further investigation into TOLLIP SNPs could offer new avenues for therapeutic strategies in IPF [8]. This evidence concerns the gene TOLLIP and idiopathic interstitial pneumonia.